Pharmaceutical Technology

JULY 28, 2022

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.

Life Science 130

Life Science Marketing Production Research 130

Pharma Times

APRIL 17, 2024

Both companies will facilitate career progression while advancing the life sciences industry

Life Science 141

Life Science Drugs Research 141

Bio Pharma Dive

MARCH 30, 2021

Two drugs developed by Wave Life Sciences didn't appear to have an effect on disease-causing proteins, another setback for Huntington's research after disappointing results last week from Roche and Ionis.

Life Science 313

Life Science Drugs Protein Trials 313

Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.

Life Science 162

Life Science Development Gene Therapy Genetics 162

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Pharmaceutical Technology

AUGUST 15, 2022

It is no secret that Canada boasts a strong and competitive life sciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge life sciences innovation. These factors have combined to make Ontario a leading force for medical research and innovation. Again, this is nothing new.

Life Science 130

Life Science Research Manufacturing Insulin 130

XTalks

OCTOBER 24, 2024

Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. The Psoriasis Diet Diet has long been an area of research as a potential factor in managing psoriasis.

Research 105

Research Dermatology Clinical Trials Clinical Trials 105

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

Life Science 115

Life Science Development Drugs Research 115

Pharmaceutical Technology

JUNE 16, 2023

The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance life sciences.

Life Science 130

Life Science Genetic Disease Genome Genomics 130

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. The post 6 research and development life sciences predictions for 2023 appeared first on.

Life Science 111

Life Science Development Research Production 111

Pharmaceutical Technology

APRIL 25, 2024

Merck has announced an investment of more than €300m ($320.8m) in a new Life Science Research Center at its global headquarters in Darmstadt, Germany.

Life Science 147

Life Science Research 147

Pharma Mirror

SEPTEMBER 6, 2023

Why Is Patient-Centric Marketing The post Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs appeared first on Pharma Mirror Magazine.

Life Science 130

Life Science Marketing Compliance Branding 130

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

MARCH 19, 2025

Join us as we celebrate a major milestone the 200th episode of the Xtalks Life Science Podcast! From groundbreaking biotech innovations to exclusive interviews with life science industry innovators and leaders, we’ve covered it all. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 110

Life Science Clinical Development Development Research 110

Pharmaceutical Technology

OCTOBER 11, 2023

The collaboration aims to boost open innovation hub SakuLab-Tsukaba at Astellas’ Tsukuba Research Centre.

Life Science 147

Life Science Research 147

XTalks

JUNE 9, 2023

Consistency is a key factor in any successful life science content marketing strategy. By keeping the conversation going, content marketers within the life science industry can build trust with their audience and create a loyal following that will continue to engage with their content and products over time.

Life Science 98

Life Science Marketing Branding Production 98

Bio Pharma Dive

SEPTEMBER 22, 2022

The grant is one of the Novo Nordisk Foundation’s largest and will fund a 12-year research collaboration to construct a quantum computer dedicated to the life sciences.

Life Science 157

Life Science Research 157

XTalks

DECEMBER 19, 2024

Another unique challenge in psychiatry trials is the placebo response, which is notably high in mental health research. Rae emphasized the need to empower and enable research sites to accommodate patients rather than patients accommodating study schedules.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Research 97

Bio Pharma Dive

JULY 22, 2024

Clinical data registries have become invaluable for generating unique insights for life sciences. Read on to learn more.

Life Science 157

Life Science Research 157

Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

XTalks

FEBRUARY 14, 2024

Yang Liu, PhD Founder, Chairman, CEO and Chief Scientific Officer OncoC4 Dr. Liu is recognized internationally for his research on immune recognition of cancer and activation of lymphocytes. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 119

Life Science DNA Production Clinical Trials 119

Cloudbyz

MARCH 17, 2024

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Life Science 81

Life Science Clinical Trials Clinical Trials Trials 81

XTalks

APRIL 7, 2025

Optum Life Sciences expert provides insights on the latest trends. Optum Life Sciences researchers stay up-to-date on the latest in research and how it may affect access for patients. Given the population level impact, what are researchers studying now? To learn more, contact Optum Life Sciences.

Life Science 52

Life Science Research Trials Manufacturing 52

Pharmaceutical Technology

JUNE 20, 2023

Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? Over the next two years, GlobalData’s thematic research unit shows further advancements in machine learning, falling into three main categories: technology, macroeconomic, and regulatory.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. IBM will also provide its knowledge to help Moderna explore the potential use cases of quantum technologies in life sciences.

Research 246

Research Gene Therapy Gene Scientist 246

XTalks

SEPTEMBER 6, 2023

David Young, PharmD, PhD President, Research & Development Processa Pharmaceuticals Dr. Young is Processa’s initial founder, President of R&D and former President and CEO. He has over 30 years of pharmaceutical research, drug development and corporate experience. Young discussed with Xtalks in this podcast episode.

Life Science 116

Life Science Drugs Development Research 116

XTalks

OCTOBER 31, 2024

Tune into the episode to hear more about the latest trial data for finerenone in heart failure and the landscape of heart failure research. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.

Life Science 52

Life Science Cardiology Trials Development 52

Pharmaceutical Technology

JUNE 28, 2024

In the evolving landscape of clinical research, the data held in primary care Electronic Health Records (EHR) has been recognised for the significant potential it offers in uncovering insights, driving innovation, and enhancing patient care.

Life Science 130

Life Science Clinical Research Research 130

XTalks

OCTOBER 24, 2024

Panagos, an industry veteran with extensive experience in the healthcare and life sciences sector, takes over from Colin Shannon, who served as CEO for one year following the company’s acquisition by a consortium of private equity firms. Shannon has now been appointed Executive Chairman of Syneos.

Life Science 105

Life Science Clinical Development Development Clinical Research 105

XTalks

OCTOBER 23, 2024

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Tune in to learn how CTTI is leading efforts to reshape clinical trials. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Clinical Research 64

Clinical Research Clinical Trials Clinical Trials Life Science 64

XTalks

SEPTEMBER 20, 2023

Tania Kamphaus and Tony Villiotti about new research on the utility and promise of blood-based biomarker tests for the diagnosis of liver diseases like non-alcoholic steatohepatitis (NASH). The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH.

Life Science 111

Life Science Research Medicine 111

pharmaphorum

JANUARY 16, 2025

Across every corner of the industry, from research and development to patient engagement, AI, and most recently generative AI (GenAI), is driving profound change.

Life Science 90

Life Science Development Research 90

XTalks

JULY 5, 2023

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Development Engineer Scientist 97

XTalks

JUNE 12, 2024

McLeod received his Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science and completed his Post-Doctoral Training at St Jude Children’s Research Hospital and the University of Glasgow. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Pharmacy Doctors Doctor 97

Pharmaceutical Technology

MAY 16, 2023

These organisations include 12 life science companies, 11 NIH institutes and centres, and ten non-profit organisations. The AMP was launched in 2014 as a partnership between the FDA , the National Institutes for Health, and several public and private organisations.

Gene Therapy 227

Gene Therapy Gene Research Clinical Trials 227

Bio Pharma Dive

AUGUST 18, 2023

The life science tools sector is ripe for consolidation, according to analysts at TD Cowen.

Life Science 130

Life Science Research 130

XTalks

SEPTEMBER 20, 2023

Tania Kamphaus and Tony Villiotti about new research on the utility and promise of blood-based biomarker tests for the diagnosis of liver diseases like non-alcoholic steatohepatitis (NASH). The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH.

Life Science 98

Life Science Research Medicine 98